ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

Immune and regenerative mechanisms in the pathogenesis of vulvovaginal atrophy: proteomic analysis of cervicovaginal fluid

Starodubtseva N.L., Nazarova N.M., Devyatkina A.R., Tokareva A.O., Kukaev E.N., Bugrova A.E., Brzhozovskiy A.G., Mezhevitinova E.A., Dovletkhanova E.R., Kepsha E.A., Frankevich V.E., Prilepskaya V.N., Sukhikh G.T.

1) Academician V.I. Kulakov National Medical Research Centre For Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, Moscow, Russia; 2) Moscow Institute of Physics and Technology, Dolgoprudny, Russia; 3) Emanuel Institute of Biochemical Physics of the Russian Academy of Sciences, Moscow Russia; 4) Skolkovo Institute of Science and Technology, Moscow; 5) Siberian State Medical University, Ministry of Health of Russia, Tomsk, Russia

Objective: Exploration of the relationship between clinical and anamnestic data, the severity of VVA, and the results of proteomic analysis of CVF to identify protein biomarkers associated with atrophic changes, inflammation, immune response, and tissue regeneration in the age group of 50–70 years.
Materials and methods: The methodological foundation of this study was a comprehensive analysis integrating the clinical and anamnestic data and proteomic analysis of cervicovaginal fluid (CVF) from patients with vulvovaginal atrophy (VVA). The study included 32 women aged 50–70 years with vulvovaginal atrophy (VVA). The comprehensive analysis included the clinical and anamnestic data, cytological examination, HPV genotyping, and analysis of the protein content of CVF. Semi-quantitative proteomic analysis (HPLC-MS/MS) including protein identification and annotation was performed using the MaxQuant and STRING software packages.
Results: Proteomic analysis of CVF identified specific protein profiles indicating activation of inflammatory processes, impaired tissue regeneration, and neurobiological mechanisms of pain sensitization. These profiles involved protein groups associated with blood microparticles and translocation of SLC2A4, both of which play an important role in occurrence of atrophic changes. Changes in PGAM1, PGAM2, and PGAM4 suggest impaired energy metabolism and the extracellular matrix synthesis, adversely affecting the proliferative activity of epithelial cells. Impaired glycine-serine metabolism reduces collagen and glutathione synthesis contributing to loss of tissue elasticity and increased susceptibility to oxidative stress. Changes in synthesis of HSPA1A and HSPA1B are associated with impaired cellular adaptive responses and lead to accumulation of damaged proteins and enhanced apoptotic death of vaginal epithelial cells.
Conclusion: Proteomic analysis identified specific protein profiles indicating inflammatory activation, impaired tissue regeneration, and neurobiological pathways of pain sensitization.

Authors' contributions: The authors made substantial contributions to drafting the article and approved the final version before publication: Sukhikh G.T. – research concept and design; Nazarova N.M., Mezhevitinova E.A., Dovletkhanova E.R., Kepsha M.A. – data acquisition and processing; Starodubtseva N.L., Tokareva A.O., Kukaev E.N., Bugrova A.E., Brzhozovskiy A.G. – proteomic sample preparation and performance of proteomic analysis; Starodubtseva N.L., Tokareva A.O., Brzhozovskiy A.G., Kukaev E.N. – statistical data processing; Nazarova , N.M.,  Devyatkina A.R., Starodubtseva N.L., Tokareva A.O., Kukaev E.N., Bugrova A.E., Brzhozovskiy A.G. – manuscript writing; Frankevich V.E., Prilepskaya V.N. –  editing and final approval of the manuscript for publication. 
Conflicts of interest: The authors confirm that they have no conflicts of interest to declare.
Funding: The study was carried out within the framework of the State Assignment No. № 12503063216-9 on the topic: “Development of a test system for early and minimally invasive diagnosis of HPV-associated precancerous and oncological diseases of the anogenital region in women of different ages using liquid biopsy”
Ethical Approval: The study was approved by the local Ethics Committee of V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia (Protocol No. 1 of January 30, 2025).
Patient Consent for Publication: All patients have signed informed consent for participation in the study and publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Starodubtseva N.L., Nazarova N.M., Devyatkina A.R., Tokareva A.O., Kukaev E.N., Bugrova A.E., Brzhozovskiy A.G., Mezhevitinova E.A., Dovletkhanova E.R., Kepsha E.A., Frankevich V.E., Prilepskaya V.N., 
Sukhikh G.T.  Immune and regenerative mechanisms in the pathogenesis of vulvovaginal atrophy: 
proteomic analysis of cervicovaginal fluid
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (12): 120-132 (in Russian)
https://dx.doi.org/10.18565/aig.2025.278

Keywords

cervicovaginal fluid
proteomic analysis
liquid chromatography–mass spectrometry
vulvovaginal atrophy
dyspareunia
GSM
genitourinary syndrome of menopause

References

  1. Ярмолинская М.И., Колошкина А.В. Алгоритм диагностики и лечения генитоуринарного менопаузального синдрома. Акушерство и гинекология. 2024; 9 (Приложение): 22-36. [Yarmolinskaya M.I., Koloshkina A.V. Algorithm for the diagnosis and treatment of genitourinary syndrome of menopause. Obstetrics and Gynecology. 2024; 9 (Suppl.): 22-36 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.181
  2. Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin. Obstet. Gynecol. 2015; 58(3): 476-91. https://dx.doi.org/10.1097/GRF.0000000000000126
  3. Оразов М.Р., Силантьева Е.С., Радзинский В.Е., Михалева Л.М., Хрипач Е.А., Долгов Е.Д. Вульвовагинальная атрофия в пери- и постменопаузе: актуальность проблемы и влияние на качество жизни. Гинекология. 2022; 24(5): 408-12. [Orazov M.R., Silantyeva E.S.,Radzinsky V.E., Mikhaleva L.M., Khripach E.A., Dolgov E.D. Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life. Gynecology. 2022; 24(5): 408-12 (in Russian)]. https://dx.doi.org/10.26442/20795696.2022.5.201854
  4. Reed S.D. Genitourinary syndrome of menopause. Clin. Obstet. Gynecol. 2024; 67(1): 1-3. https://dx.doi.org/10.1097/grf.0000000000000843
  5. Freedman M.A. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey. Women’s Heal. (Lond). 2014; 10(4): 445-54. https://dx.doi.org/10.2217/whe.14.29
  6. Li S., Herrera G.G., Tam K.K., Lizarraga J.S., Beedle M.T., Winuthayanon W. Estrogen action in the epithelial cells of the mouse vagina regulates neutrophil infiltration and vaginal tissue integrity. Sci. Rep. 2018; 8(1): 11247. https://dx.doi.org/10.1038/s41598-018-29423-5
  7. Li Y., Shoyele O., Shidham V.B. Pattern of cervical biopsy results in cases with cervical cytology interpreted as higher than low grade in the background with atrophic cellular changes. Cytojournal. 2020; 17: 12. https://dx.doi.org/10.25259/cytojournal_82_2019
  8. Traish A.M., Vignozzi L., Simon J.A., Goldstein I., Kim N.N. Role of androgens in female genitourinary tissue structure and function: implications in the genitourinary syndrome of menopause. Sex. Med. Rev. 2018; 6(4): 558-71. https://dx.doi.org/10.1016/j.sxmr.2018.03.005
  9. Bertin J., Dury A.Y., Ouellet J., Pelletier G., Labrie F. Localization of the androgen-synthesizing enzymes, androgen receptor, and sex steroids in the vagina: possible implications for the treatment of postmenopausal sexual dysfunction. J. Sex. Med. 2014; 11(8): 1949-61. https://dx.doi.org/10.1111/jsm.12589
  10. Witherby S., Johnson J., Demers L., Mount S., Littenberg B., Maclean C.D. et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. Oncologist. 2011; 16(4): 424-31. https://dx.doi.org/10.1634/theoncologist.2010-0435
  11. Comeglio P., Cellai I., Filippi S., Corno C., Corcetto F., Morelli A. et al. Differential effects of testosterone and estradiol on clitoral function: an experimental study in rats. J. Sex. Med. 2016; 13(12): 1858-71. https://dx.doi.org/10.1016/j.jsxm.2016.10.007
  12. Франкевич В.Е., Назарова Н.М., Довлетханова Э.Р., Гусаков К.И., Кононихин А.С., Бугрова А.Е., Бржозовский А.Г., Прилепская В.Н., Стародубцева Н.Л., Сухих Г.Т. Протеомный анализ цервиковагинальной жидкости при применении активированной глицирризиновой кислоты у пациенток с ВПЧ-ассоциированными поражениями шейки матки. Акушерство и гинекология. 2022; 5: 109-17. [Frankevich V.E., Nazarova N.M., Dovlethanova E.R., Gusakov K.I. , Kononikhin A.S., Bugrova A.E., Brzhozovskiy A.G., Prilepskaya V.N., Chagovets V.V., Starodubtseva N.L., Sukhikh G.T. Proteomic analysis of cervicovaginal fluid of patients with HPV-associated cervical lesions treated with activated glycyrrhizic acid. Obstetrics and Gynecology. 2022; (5): 109-17 (in Russian)].https://dx.doi.org/10.18565/aig.2022.5.109-117
  13. Зардиашвили М.Д., Франкевич В.Е., Назарова Н.М., Бугрова А.Е., Кононихин А.С., Бржозовский А.Г., Стародубцева Н.Л., Асатурова А.В., Сухих Г.Т. Характеристика изменений протеомного состава цервиковагинальной жидкости при заболеваниях шейки матки, ассоциированных с ВПЧ-инфекцией. Акушерство и гинекология. 2017; 4: 88-94. [Zardiashvili M.D., Frankevich V.E., Nazarova N.M., Bugrova A.E., Kononikhin A.S., Brhozovsky А.G., Starodubtseva N.L., Asaturova A.V., Sukhikh G.T. Proteomic composition of cervicovaginal fluid in cervical diseases associated with HPV infection. Obstetrics and Gynecology. 2017; (4): 88-94 (in Russian)]. https://dx.doi.org/10.18565/aig.2017.4.88-94
  14. Starodubtseva N.L., Brzhozovskiy A.G., Bugrova A.E., Kononikhin A.S., Indeykina M.I., Gusakov K.I. et al. Label-free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation. J. Mass Spectrom. 2019; 54(8): 693-703. https://dx.doi.org/10.1002/jms.4374
  15. Mukherjee A., Pednekar C.B., Kolke S.S., Kattimani M., Duraisamy S., Burli A.R. et al. Insights on proteomics-driven body fluid-based biomarkers of cervical cancer. Proteomes. 2022; 10(2): 13. https://dx.doi.org/10.3390/proteomes10020013
  16. Vagios S., Mitchell C.M. Mutual preservation: a review of interactions between cervicovaginal mucus and microbiota. Front. Cell. Infect. Microbiol. 2021; 11: 676114. https://dx.doi.org/10.3389/fcimb.2021.676114
  17. Starodubtseva N.L., Brzhozovskiy A.G., Bugrova A.E., Kononikhin A.S., Gusakov K.I., Nazarova N.M. et al. Characteristics of dynamic changes in proteomic composition of cervicovaginal fluid in cervical diseases associated with HPV infection. Obstet. Gynecol. 2020; 7: 111-6. https://dx.doi.org/10.18565/aig.2020.7.111-116
  18. Liu D., Zhao L., Jiang Y., Li L., Guo M., Mu Y. et al. Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes. J. Cachexia Sarcopenia Muscle. 2022; 13(5): 2456-72. https://dx.doi.org/10.1002/jcsm.13045
  19. Ji S., Liu Y., Yan L., Zhang Y., Li Y., Zhu Q. et al. DIA-based analysis of the menstrual blood proteome identifies association between CXCL5 and IL1RN and endometriosis. J. Proteomics. 2023; 289: 104995. https://dx.doi.org/10.1016/j.jprot.2023.104995
  20. Szklarczyk D., Kirsch R., Koutrouli M., Nastou K., Mehryary F., Hachilif R. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023; 51(D1): D638-46. https://dx.doi.org/10.1093/nar/gkac1000
  21. Huang S., Czech M.P. The GLUT4 glucose transporter. Cell Metab. 2007; 5(4): 237-52. https://dx.doi.org/10.1016/j.cmet.2007.03.006
  22. Amabebe E., Anumba D.O.C. The vaginal microenvironment: the physiologic role of Lactobacilli. Front. Med. 2018; 5: 181. https://dx.doi.org/10.3389/fmed.2018.00181
  23. Vanhoutte P.M., Shimokawa H., Feletou M., Tang E.H.C. Endothelial dysfunction and vascular disease – a 30th anniversary update. Acta Physiol. 2017; 219(1): 22-96. https://dx.doi.org/10.1111/apha.12646
  24. Locasale J.W. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer. 2013; 13(8): 572-83. https://dx.doi.org/10.1038/nrc3557
  25. Hitosugi T., Zhou L., Elf S., Fan J., Kang H.B., Seo J.H. et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell. 2012; 22(5): 585-600. https://dx.doi.org/10.1016/j.ccr.2012.09.020
  26. Walenta S., Wetterling M., Lehrke M., Schwickert G., Sundfør K., Rofstad E.K. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000; 60(4): 916-21
  27. Amelio I., Cutruzzolá F., Antonov A., Agostini M., Melino G. Serine and glycine metabolism in cancer. Trends Biochem. Sci. 2014; 39(4): 191-8. https://dx.doi.org/10.1016/j.tibs.2014.02.004
  28. Rosenzweig R., Nillegoda N.B., Mayer M.P., Bukau B. The Hsp70 chaperone network. Nat. Rev. Mol. Cell Biol. 2019; 20(11): 665-80. https://dx.doi.org/10.1038/s41580-019-0133-3
  29. Voss M.R., Stallone J.N., Li M., Cornelussen R.N.M., Knuefermann P., Knowlton A.A. Gender differences in the expression of heat shock proteins: the effect of estrogen. Am. J. Physiol. Heart Circ. Physiol. 2003; 285(2): H687-92. https://dx.doi.org/10.1152/ajpheart.01000.2002
  30. Zegels G., Van Raemdonck G.A.A., Tjalma W.A.A., Van Ostade X.W.M. Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract. Proteome Sci. 2010; 8: 63. https://dx.doi.org/10.1186/1477-5956-8-63
  31. Jeyakumari P., Shakeela G. The role of the immune system in maintaining homeostasis. J. Biomed. Pharm. Res. 2025; 14(2): 54-65. https://dx.doi.org/10.32553/jbpr.v14i2.1258
  32. Chen L., Deng H., Cui H., Fang J., Zuo Z., Deng J. et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018; 9(6): 7204-18. https://dx.doi.org/10.18632/oncotarget.23208
  33. Torelli F.R., Rodrigues-Peres R.M., Monteiro I., Lopes-Cendes I., Bahamondes L., Juliato C.R.T. Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study. Sci. Rep. 2024; 14(1): 11062. https://dx.doi.org/10.1038/s41598-024-61751-7
  34. Wilhelm G., Mertowska P., Mertowski S., Przysucha A., Strużyna J., Grywalska E. et al. The crossroads of the coagulation system and the immune system: interactions and connections. Int. J. Mol. Sci. 2023; 24(16): 12563. https://dx.doi.org/10.3390/ijms241612563
  35. Mwaura A.N., Marshall N., Anglesio M.S., Yong P.J. Neuroproliferative dyspareunia in endometriosis and vestibulodynia. Sex. Med. Rev. 2023; 11(4): 323-32. https://dx.doi.org/10.1093/sxmrev/qead033
  36. Li T., Ma Y., Zhang H., Yan P., Huo L., Hu Y. et al. Estrogen replacement regulates vaginal innervations in ovariectomized adult virgin rats: a histological study. Biomed. Res. Int. 2017; 2017: 7456853. https://dx.doi.org/10.1155/2017/7456853
  37. Mónica Brauer M., Smith P.G. Estrogen and female reproductive tract innervation: cellular and molecular mechanisms of autonomic neuroplasticity. Auton. Neurosci. 2015; 187: 1-17. https://dx.doi.org/10.1016/j.autneu.2014.11.009
  38. Ting A.Y., Blacklock A.D., Smith P.G. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol. Reprod. 2004; 71(4): 1397-404. https://dx.doi.org/10.1095/biolreprod.104.030023
  39. Beck L.A., Cork M.J., Amagai M., De Benedetto A., Kabashima K., Hamilton J.D. et al. Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov. 2022; 2(5): 100131. https://dx.doi.org/10.1016/j.xjidi.2022.100131
  40. Takahashi S., Ishida A., Kubo A., Kawasaki H., Ochiai S., Nakayama M. et al. Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier-impaired skin during chronic itch development. Sci. Rep. 2019; 9(1): 8625. https://dx.doi.org/10.1038/s41598-019-44866-0
  41. Falsetta M.L., Foster D.C., Woeller C.F., Pollock S.J., Bonham A.D., Haidaris C.G. et al. A role for bradykinin signaling in chronic vulvar pain. J. Pain. 2016; 17(11): 1183-97. https://dx.doi.org/10.1016/j.jpain.2016.07.007
  42. Thangam E.B., Jemima E.A., Singh H., Baig M.S., Khan M., Mathias C.B. et al. The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. Front. Immunol. 2018; 9: 1873. https://dx.doi.org/10.3389/fimmu.2018.01873
  43. Cai Y., Li J., Fan K., Zhang D., Lu H., Chen G. Downregulation of chloride voltage-gated channel 7 contributes to hyperalgesia following spared nerve injury. J. Biol. Chem. 2024; 300(10): 107779. https://dx.doi.org/10.1016/j.jbc.2024.107779
  44. Albrecht J., Sidoryk-Wȩgrzynowicz M., Zielińska M., Aschner M. Roles of glutamine in neurotransmission. Neuron Glia Biol. 2010; 6(4): 263-76. https://dx.doi.org/10.1017/S1740925X11000093
  45. Yamanaka H., Kobayashi K., Okubo M., Noguchi K. Annexin A2 in primary afferents contributes to neuropathic pain associated with tissue type plasminogen activator. Neuroscience. 2016; 314: 189-99. https://dx.doi.org/10.1016/j.neuroscience.2015.11.058

Received 02.10.2025

Accepted 19.12.2025

About the Authors

Natalia L. Starodubtseva, PhD (Bio), Head of the Laboratory of Clinical Proteomics, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, Russia, n_starodubtseva@oparina4.ru, https://orcid.org/0000-0001-6650-5915
Niso M. Nazarova, Dr. Med. Sci., Leading Researcher, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, Russia, n_nazarova@oparina4.ru, https://orcid.org/0000-0001-9499-7654
Anastasia R. Devyatkina, obstetrician-gynecologist, PhD student, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, Russia, grinasta26@mail.ru, https://orcid.org/0009-0006-1742-7555
Alisa O. Tokareva, PhD (Phys.-Math.), Specialist at the Laboratory of Clinical Proteomics, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, Russia, alisa.tokareva@phystech.edu, https://orcid.org/0000-0001-5918-9045
Evgenii N. Kukaev, PhD (Phys.-Math.), PhD, Senior Researcher at the Laboratory of Clinical Proteomics, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, Russia; Moscow Institute of Physics and Technology, e_kukaev@oparina4.ru, https://orcid.org/0000-0002-8397-3574
Anna E. Bugrova, PhD (Bio), Senior Researcher at the Laboratory of Proteomics of Human Reproduction, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, Russia; Senior Researcher, Laboratory of Neurochemistry, Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, a_bugrova@oparina4.ru
Alexander G. Brzhozovskiy, PhD (Bio), Senior Researcher at the Laboratory of Proteomics of Human Reproduction, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997; Junior Researcher at the Laboratory of Mass Spectrometry,
Skolkovo Institute of Science and Technology, agb.imbp@gmail.com
Elena A. Mezhevitinova, Dr. Med. Sci., Leading Researcher at the Scientific and Polyclinic Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, mejevitinova@mail.ru, https://orcid.org/0000-0003-2977-9065
Elmira R. Dovletkhanova, PhD, Senior Researcher at the Scientific and Polyclinic Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, eldoc@mail.ru, https://orcid.org/0000-0003-2835-6685
Maria A. Kepsha, Junior Researcher, doctor at the Scientific and Polyclinic Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, m_kepsha@oparina4.ru, https://orcid.org/0000-0002-4201-1360
Vladimir E. Frankevich, Dr. Sci. (Phys.-Math.), Deputy Director of the Institute of Translational Medicine, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997; Siberian State Medical University, Ministry of Health of Russia,
v_frankevich@oparina4.ru, https://orcid.org/0000-0002-9780-4579
Vera N. Prilepskaya, Dr. Med. Sci., Professor, Honored Scientist of the Russian Federation, Head of the Scientific and Polyclinic Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, v_prilepskaya@oparina4.ru,
https://orcid.org/0000-0003-3993-7629
Gennady T. Sukhikh, Dr. Med. Sci., Professor, Academician of the RAS, Director, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 4, Oparina str., Moscow, 117997, sekretariat@oparina4.ru, https://orcid.org/0000-0002-7712-1260

Similar Articles